KV
K. Vanasse
Hematology & Oncology
Credentials: ·
Research
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Proceedings of the National Academy of Sciences of the United States of America · 2013 · 717 citations
The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1
Nature · 2017 · 485 citations
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
New England Journal of Medicine · 2019 · 370 citations
- NB
7 papers
3 papers
3 papers · 1 as a fellow
- AS
3 papers
- DW
3 papers
- MF
3 papers
- AJ
2 papers
2 papers
